Cellworks
Telecommunications · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Hanlan Rd Unit 8, Woodbridge, Ontari...Phone Number
(905) 670-1980Website
www.cellworks.caRevenue
<$5 MillionIndustry
About Cellworks
Cellworks Org Chart
Is Cellworks your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cellworks
Funding: Get notified immidiatlly once Cellworks has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cellworks had a recent Job posting/layoffs
Check if Cellworks has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cellworks launches new products
Cellworks, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Cellworks recently announced quarterly report
Check out if Cellworks is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Cellworks as Masked Content
Find more new buyers
Compare Similar Companies to Cellworks
Compare insights from companies similar to Cellworks, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cellworks is experiencing very low activity levels compared to other companies in the Telecommunications sector.
What does this means?
Cellworks is drawing exceptional interest within the Telecommunications industry, suggesting notable developments or strong market momentum, learn more about Cellworks.
Cellworks Tech Stack
A closer look at the technologies used by Cellworks
Cellworks News & Media
Cellworks Enhances TRI with Personalized Tumor Microenvironment Modeling to Predict Overall Survival in NSCLC Patients Receiving Immunotherapy
HOUSTON--(BUSINESS WIRE)--Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced results from a study demonstrating the efficacy of the Cellworks Therapy Response Index (TRI) combined with personalized tumor microenvironment (TME) modeling in predicting overall survival (OS) for non-small cell lung cancer (NSCLC) patients receiving immunotherapy (IO). This comprehensive approach enables more precise identification of patient-speciCellworks Biosimulation Combined with Tumor Microenvironment Modeling Enhances Predictions of IO Response in NSCLC Patients
BARCELONA, Spain--(BUSINESS WIRE)--Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced results from a study using Cellworks computational biosimulation to predict how individual non-small cell lung cancer (NSCLC) patients will respond to immunotherapy (IO) treatment by combining biosimulation with personalized tumor microenvironment (P-TME) modeling. The research found that biosimulation is highly effective for predicting immunCellworks Biosimulation Predicts PARPi Benefit in Patients with Ovarian, Pancreatic, Prostate and Triple-Negative Breast Cancers
BARCELONA, Spain--(BUSINESS WIRE)--Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced results from a study using the Cellworks Platform to predict homologous recombination deficiency (HRD) and the effectiveness of PARP inhibitors (PARPi) in real-world cohorts of patients with ovarian, pancreatic, prostate, and triple-negative breast cancers (TNBC). This research highlights the potential of the Cellworks mechanistic biosimulatiCellworks Biosimulation Identifies which NSCLC Patients will Benefit from Combining Chemotherapy with Immunotherapy
SAN DIEGO--(BUSINESS WIRE)--Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced results from a study, where Cellworks' biosimulation platform accurately predicted overall survival (OS) and chemotherapy benefit in two real-world non-small cell lung cancer (NSCLC) patients cohorts. The study showcases Cellworks’ ability to advance personalized cancer treatment by identifying NSCLC patients most likely to benefit from combining im
Top Telecommunications Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cellworks
Cellworks is a Rogers Authorized Partner that serves the Canadian business market, catering to clients ranging from individual business owners to large corporations. The company specializes in providing solutions for the small and medium business market, with business offices located in British Columbia and Ontario. Cellworks focuses on managing th... Read More